| P50 | author | Janet Daling | Q20807295 |
| | Robert W Mathes | Q88921945 |
| | Kathleen E. Malone | Q110376035 |
| | Peggy L. Porter | Q110376451 |
| P2093 | author name string | Scott Davis | |
| | Christopher I Li | |
| | Sylvia M Lucas | |
| P2860 | cites work | Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative | Q28165551 |
| | Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk | Q28168742 |
| | Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status | Q28176257 |
| | Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited | Q28181502 |
| | A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence | Q28182821 |
| | Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer | Q28194496 |
| | Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort | Q28213690 |
| | Sex hormones and headache 1999 (menstrual migraine). | Q33733109 |
| | Sex hormones and headache | Q34119414 |
| | Prevention of menstrual migraine by percutaneous oestradiol | Q34290661 |
| | Prevalence of migraine on each day of the natural menstrual cycle | Q34336315 |
| | Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. | Q34341673 |
| | The influence of estrogen on migraine: a systematic review | Q34514773 |
| | Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis | Q34558956 |
| | Diverse actions of ovarian steroids in the serotonin neural system | Q34572423 |
| | Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors | Q34608627 |
| | Understanding breast cancer risk -- where do we stand in 2005? | Q36077410 |
| | Breast cancer and NSAID use: a meta-analysis | Q36622959 |
| | Hormonal changes throughout life in women | Q36625029 |
| | Potential role of female sex hormones in the pathophysiology of migraine | Q36636791 |
| | Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study | Q36678729 |
| | Hormonal management of migraine associated with menses and the menopause: a clinical review | Q36735671 |
| | Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas | Q37058705 |
| | A prospective study of endogenous estrogens and breast cancer in postmenopausal women | Q39378468 |
| | Medication use and the risk of breast cancer | Q39796441 |
| | The prevalence and characteristics of migraine in a population-based cohort: the GEM study | Q40801339 |
| | Prospective study of regular aspirin use and the risk of breast cancer | Q41007088 |
| | Menstrual migraines: etiology, treatment, and relationship to premenstrual syndrome. | Q41571225 |
| | Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women | Q44053417 |
| | Nonsteroidal antiinflammatory drugs and breast cancer | Q44378169 |
| | Relationship between long durations and different regimens of hormone therapy and risk of breast cancer | Q44489759 |
| | Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA). | Q44768685 |
| | Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques | Q44938358 |
| | Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women | Q45188730 |
| | Differential distribution of estrogen receptor (ER)-alpha and ER-beta in the midbrain raphe nuclei and periaqueductal gray in male mouse: Predominant role of ER-beta in midbrain serotonergic systems | Q45234095 |
| | Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). | Q46495873 |
| | Antidepressant use and breast cancer risk | Q46831629 |
| | Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65–79 years | Q47606588 |
| | Characteristics of headache at menopause: a clinico-epidemiologic study. | Q48865842 |
| | A cohort study of antihypertensive medication use and breast cancer among Danish women. | Q50543915 |
| | Headache during gestation: evaluation of 1101 women. | Q53233774 |
| | Migraine in the United States: epidemiology and patterns of health care use. | Q53316530 |
| | Oral contraceptives and the risk of breast cancer. | Q55035937 |
| | The Relationship of Nonsteroidal Anti-inflammatory Drug Use to the Risk of Breast Cancer | Q59763658 |
| | Menstrual migraine: a double-blind trial of percutaneous estradiol | Q70225080 |
| | Course of migraine during pregnancy and postpartum: a prospective study | Q73185280 |
| | Menstrual cycle and headache in a population sample of migraineurs | Q73230734 |
| | Cancer risk and mortality in users of calcium channel blockers. A cohort study | Q74008896 |
| | Medical consultation for migraine: results from the American Migraine Study | Q74407275 |
| | Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women | Q79182457 |
| P433 | issue | 11 | |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 3116-3122 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Migraine in postmenopausal women and the risk of invasive breast cancer | |
| P478 | volume | 17 | |